RxDoctor Payments Data

Grant Karno, MD

Pain Medicine · Las Vegas, NVNPI 1124462056

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 88.1% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for pain medicine clinicians in NV, where the typical reported total is $2,557.

$1,917in general payments, 2019–2025

Across 114 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Curonix LLC$155
  • Boston Scientific$73

What the payments were for

  • Food & beverage$1,917100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott108$1,689
Curonix LLC4$155
Boston Scientific2$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,917 in reported general payments places this provider in the 40th percentile of 101 pain medicine providers in Nevada.

See all pain medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$105,705
Medicare patients
239
Services billed
1,059

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl40$15,938
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen237$9,655
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen220$5,022
Oxycodone Hcl123$2,620
Gabapentin227$2,414
Pregabalin104$1,551
Lidocaine16$1,325
Tizanidine Hcl184$1,298
Methocarbamol93$1,069
Diclofenac Sodium76$931
Morphine Sulfate ErMorphine Sulfate40$819
Celecoxib22$807
Ibuprofen64$720
Cephalexin65$714
Duloxetine Hcl44$491

Paid to pharmacies, not to this prescriber.

Other pain medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →